Ana Romero-Vazquez
Stockholm, AB, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Brain exposure of the ATM inhibitor AZD1390 in humans-a positron emission tomography study.
Journal: Neuro-oncology
Published: October 30, 2020
Synthesis and Preclinical Evaluation of 6-[18F]Fluorine-α-methyl-l-tryptophan, a Novel PET Tracer for Measuring Tryptophan Uptake.
Journal: ACS chemical neuroscience
Published: April 29, 2020
Quantification and reliability of [11C]VC - 002 binding to muscarinic acetylcholine receptors in the human lung - a test-retest PET study in control subjects.
Journal: EJNMMI research
Published: January 15, 2020
Preclinical Comparison of the Blood-brain barrier Permeability of Osimertinib with Other EGFR TKIs.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 07, 2019
A PET study in healthy subjects of brain exposure of 11C-labelled osimertinib - A drug intended for treatment of brain metastases in non-small cell lung cancer.
Journal: Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism
Published: April 23, 2019
Increased Brain Exposure of an Alpha-Synuclein Fibrillization Modulator by Utilization of an Activated Ester Prodrug Strategy.
Journal: ACS chemical neuroscience
Published: June 15, 2018
2,2-Diiododimedone: a mild electrophilic iodinating agent for the selective synthesis of α-iodoketones from allylic alcohols.
Journal: Chemical communications (Cambridge, England)
Published: August 16, 2017
General, Simple, and Chemoselective Catalysts for the Isomerization of Allylic Alcohols: The Importance of the Halide Ligand.
Journal: Chemistry (Weinheim an der Bergstrasse, Germany)
Published: August 10, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026